These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28747192)

  • 1. The European ME/CFS Biomarker Landscape project: an initiative of the European network EUROMENE.
    Scheibenbogen C; Freitag H; Blanco J; Capelli E; Lacerda E; Authier J; Meeus M; Castro Marrero J; Nora-Krukle Z; Oltra E; Strand EB; Shikova E; Sekulic S; Murovska M
    J Transl Med; 2017 Jul; 15(1):162. PubMed ID: 28747192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME/CFS in Europe.
    Nacul L; Authier FJ; Scheibenbogen C; Lorusso L; Helland IB; Martin JA; Sirbu CA; Mengshoel AM; Polo O; Behrends U; Nielsen H; Grabowski P; Sekulic S; Sepulveda N; Estévez-López F; Zalewski P; Pheby DFH; Castro-Marrero J; Sakkas GK; Capelli E; Brundsdlund I; Cullinan J; Krumina A; Bergquist J; Murovska M; Vermuelen RCW; Lacerda EM
    Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34069603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and incidence of myalgic encephalomyelitis/chronic fatigue syndrome in Europe-the Euro-epiME study from the European network EUROMENE: a protocol for a systematic review.
    Estévez-López F; Castro-Marrero J; Wang X; Bakken IJ; Ivanovs A; Nacul L; Sepúlveda N; Strand EB; Pheby D; Alegre J; Scheibenbogen C; Shikova E; Lorusso L; Capelli E; Sekulic S; Lacerda E; Murovska M;
    BMJ Open; 2018 Sep; 8(9):e020817. PubMed ID: 30181183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceptions of European ME/CFS Experts Concerning Knowledge and Understanding of ME/CFS among Primary Care Physicians in Europe: A Report from the European ME/CFS Research Network (EUROMENE).
    Cullinan J; Pheby DFH; Araja D; Berkis U; Brenna E; de Korwin JD; Gitto L; Hughes DA; Hunter RM; Trepel D; Wang-Steverding X
    Medicina (Kaunas); 2021 Feb; 57(3):. PubMed ID: 33652747
    [No Abstract]   [Full Text] [Related]  

  • 5. The Role of Prevention in Reducing the Economic Impact of ME/CFS in Europe: A Report from the Socioeconomics Working Group of the European Network on ME/CFS (EUROMENE).
    Pheby DFH; Araja D; Berkis U; Brenna E; Cullinan J; de Korwin JD; Gitto L; Hughes DA; Hunter RM; Trepel D; Wang-Steverding X
    Medicina (Kaunas); 2021 Apr; 57(4):. PubMed ID: 33923830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into Metabolite Diagnostic Biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Yamano E; Watanabe Y; Kataoka Y
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Literature Review of GP Knowledge and Understanding of ME/CFS: A Report from the Socioeconomic Working Group of the European Network on ME/CFS (EUROMENE).
    Pheby DFH; Araja D; Berkis U; Brenna E; Cullinan J; de Korwin JD; Gitto L; Hughes DA; Hunter RM; Trepel D; Wang-Steverding X
    Medicina (Kaunas); 2020 Dec; 57(1):. PubMed ID: 33374291
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of Long-Term Cryopreservation on Blood Immune Cell Markers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Biomarker Discovery.
    Gómez-Mora E; Carrillo J; Urrea V; Rigau J; Alegre J; Cabrera C; Oltra E; Castro-Marrero J; Blanco J
    Front Immunol; 2020; 11():582330. PubMed ID: 33329554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review.
    Maksoud R; Magawa C; Eaton-Fitch N; Thapaliya K; Marshall-Gradisnik S
    BMC Med; 2023 May; 21(1):189. PubMed ID: 37226227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myalgic encephalomyelitis/chronic fatigue Syndrome (ME/CFS): Investigating care practices pointed out to disparities in diagnosis and treatment across European Union.
    Strand EB; Nacul L; Mengshoel AM; Helland IB; Grabowski P; Krumina A; Alegre-Martin J; Efrim-Budisteanu M; Sekulic S; Pheby D; Sakkas GK; Sirbu CA; Authier FJ;
    PLoS One; 2019; 14(12):e0225995. PubMed ID: 31805176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study.
    Lidbury BA; Kita B; Lewis DP; Hayward S; Ludlow H; Hedger MP; de Kretser DM
    J Transl Med; 2017 Mar; 15(1):60. PubMed ID: 28302133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Turning a Corner in ME/CFS Research.
    Pheby DFH; Friedman KJ; Murovska M; Zalewski P
    Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myalgic encephalomyelitis, chronic fatigue syndrome: An infectious disease.
    Underhill RA
    Med Hypotheses; 2015 Dec; 85(6):765-73. PubMed ID: 26604026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Evidence for an autoimmune disease.
    Sotzny F; Blanco J; Capelli E; Castro-Marrero J; Steiner S; Murovska M; Scheibenbogen C;
    Autoimmun Rev; 2018 Jun; 17(6):601-609. PubMed ID: 29635081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome.
    Gravelsina S; Vilmane A; Svirskis S; Rasa-Dzelzkaleja S; Nora-Krukle Z; Vecvagare K; Krumina A; Leineman I; Shoenfeld Y; Murovska M
    Front Immunol; 2022; 13():928945. PubMed ID: 36300129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
    Brenu EW; van Driel ML; Staines DR; Ashton KJ; Ramos SB; Keane J; Klimas NG; Marshall-Gradisnik SM
    J Transl Med; 2011 May; 9():81. PubMed ID: 21619669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs).
    Morris G; Berk M; Galecki P; Maes M
    Mol Neurobiol; 2014 Apr; 49(2):741-56. PubMed ID: 24068616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against ß2-adrenergic receptors.
    Wirth K; Scheibenbogen C
    Autoimmun Rev; 2020 Jun; 19(6):102527. PubMed ID: 32247028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Development of a Consistent Europe-Wide Approach to Investigating the Economic Impact of Myalgic Encephalomyelitis (ME/CFS): A Report from the European Network on ME/CFS (EUROMENE).
    Pheby DFH; Araja D; Berkis U; Brenna E; Cullinan J; de Korwin JD; Gitto L; Hughes DA; Hunter RM; Trepel D; Wang-Steverding X
    Healthcare (Basel); 2020 Apr; 8(2):. PubMed ID: 32272608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of Activin B as a Clinical Biomarker in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Gravelsina S; Nora-Krukle Z; Vilmane A; Svirskis S; Vecvagare K; Krumina A; Murovska M
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.